2023, BioTech, Digital Health and Health Technology

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science

Life Science Digital Health EHR BioTech

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Healthcare IT Today

OCTOBER 11, 2023

Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. Independent technology evaluators at the Peterson Health Technology Institute will focus initial assessments RPM for diabetes management and virtual musculoskeletal care.

Life Science

Life Science EHR BioTech RCM

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science

Life Science Digital Health Drug Development Patient Experience

Connected Health Pulse

Emerging trends in the European HealthTech M&A market 2023

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Stay Connected